We are thrilled to announce our sixth webinar session. Save the date: it will take place on 11 February at 16:00 CET, featuring a presentation by Vânia André, IMPACTIVE researcher from IST-ID.
Meet our partner Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento (IST-ID), who develops multicomponent systems to enhance the properties of our molecules. They also carry out the critical task of characterising the compounds that IMPACTIVE synthesises.
We’re turning three years old, and we’re celebrating by publishing our latest Annual Report, which summarises our developments over the past year.
Our researchers at Trinity College Dublin, in Ireland, master the spray drying technique. This team is exploring how to apply such method to achieve greener pharmaceuticals with a strong focus on industrial production.
We have used resonant acoustic mixing to study three reactions in organic chemistry and prepare APIs at the multigram scale. The results, published in ChemSusChem, outperformed traditional-solvent based chemistry.
We’re launching our IMPACTIVE webinar series to discuss mechanochemistry, green pharmaceuticals, and green chemistry. Save the date: our first session will take place on 28 May at 12:00 pm (noon) CEST, with a presentation by Evelina Colacino, our project coordinator.
Emmanuel Mignot visited the Institut Charles Gerhardt Montpellier (ICGM) at the University of Montpellier, France, to discover more about IMPACTIVE. It was an exceptional opportunity to exchange ideas and strengthen relations with our Estonian partners.
This pioneering study, using a drum mill for the first time for co-crystal formation, opens new pathways for sustainable, large-scale pharmaceutical co-crystal production
The IMPACTIVE project is launching a spin-off company. We’re looking for a visionary CEO to lead the way and shape the future of sustainable API manufacturing.
Our researchers from Radboud University are at the core of IMPACTIVE. This team works on exploring new reactions to synthesise pharmacologically active compounds at a lab scale while avoiding the use of solvents.